Pyoderma Gangrenosum
📧 Sign up to get email alerts when something new happens for Pyoderma Gangrenosum.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-08-11Clinical Trial Update: Autologous Platelet-Rich Plasma Therapy in the Treatment of Pyoderma Gangrenosum [NA]
A clinical trial evaluating autologous platelet-rich plasma therapy for Pyoderma Gangrenosum has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-06-27Clinical Trial Update: Deucravacitinib in PG [EARLY_Phase 1]
The EARLY Phase 1 trial of deucravacitinib for pyoderma gangrenosum has been withdrawn.